Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Teghesti, Tecleab"'
Autor:
Charlotta Nilsson, Bo Hejdeman, Karina Godoy-Ramirez, Teghesti Tecleab, Gabriella Scarlatti, Andreas Bråve, Patricia L Earl, Richard R Stout, Merlin L Robb, Robin J Shattock, Gunnel Biberfeld, Eric Sandström, Britta Wahren
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131748 (2015)
We compared safety and immunogenicity of intradermal (ID) vaccination with and without electroporation (EP) in a phase I randomized placebo-controlled trial of an HIV-DNA prime HIV-MVA boost vaccine in healthy Swedish volunteers.HIV-DNA plasmids enco
Externí odkaz:
https://doaj.org/article/d93a21743f804a9d8098b0c16624a23d
Autor:
Alex Assuied, Izabella Zarea, Loïc Coutte, Ken Solovay, Jann Storsaeter, Delphine Jean, Keith Rubin, Åsa Linde, Claire Bauduin, Sonia Gueguen, Nina Ekholm, Dominique Raze, Teghesti Tecleab, Erla Sigurdardottir, Noémie Mercier, Laetitia Moinot, Margaretha Ljungman, Margareta Gustafsson, Florence Allais, Cecilia Lång, Nathalie Mielcarek, Gabrielle Derocle, Eva Hanson Pihlainen, Inga-Lill Reinholdsson, Marcel Thalen, Cédrick Wallet, Camille Locht, Philippe Reboud, Nabil Al-Tawil, Geneviève Chêne, Hélène Espérou, Alpha Diallo, Maja Jahnmatz, Ludivine Taïeb, Emilie Rousseau, Teodora Aktas, Fabien Le Marec, Camille Gilbert, Ingrid Andersson, Céline Colin, Céline Roy, Christine Schwimmer, Maria Nastase, Lena Dager, Maj Ringman, Rigmor Thorstensson, Anne-Sophie Debrie, Lena Wehlin, Anneli Wahlberg, Claire Lévy-Marchal, Laura Richert
Publikováno v:
The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2020, ⟨10.1016/s1473-3099(20)30274-7⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, ⟨10.1016/s1473-3099(20)30274-7⟩
The Lancet Infectious Diseases, 2020, ⟨10.1016/s1473-3099(20)30274-7⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, ⟨10.1016/s1473-3099(20)30274-7⟩
Summary Background Long-term protection and herd immunity induced by existing pertussis vaccines are imperfect, and a need therefore exists to develop new pertussis vaccines. This study aimed to investigate the safety, colonisation, and immunogenicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a47cf071894c2c14229d531ae89de4c8
https://www.hal.inserm.fr/inserm-02904617/file/S1473309920302747.pdf
https://www.hal.inserm.fr/inserm-02904617/file/S1473309920302747.pdf
Autor:
Guido Ferrari, Patricia L. Earl, Charlotta Nilsson, Said Aboud, Merlin L. Robb, Valentina Liakina, Britta Wahren, Patricia Munseri, Eric Sandström, Eligius Lyamuya, Teghesti Tecleab, Agricola Joachim, Gabriella Scarlatti, Gunnel Biberfeld, Bernard Moss, Fred Mhalu, Muhammad Bakari
Publikováno v:
AIDS Research and Human Retroviruses. 33:880-888
We explored the duration of immune responses and the effect of a late third HIV-modified vaccinia virus Ankara (MVA) boost in HIV-DNA primed and HIV-MVA boosted Tanzanian volunteers. Twenty volunteers who had previously received three HIV-DNA and two
Autor:
Keith Rubin, Karin Loré, Marianne van Hage, Maja Jahnmatz, Danijela Apostolovic, Ang Lin, Frank Liang, Rigmor Thorstensson, Chenyan Wu, Camille Locht, Marcel Thalen, Teghesti Tecleab, Sebastian Ols, Kenneth S. Solovay
Publikováno v:
J Clin Invest
BACKGROUND: The live attenuated BPZE1 vaccine candidate induces protection against B. pertussis and prevents nasal colonization in animal models. Here we report on the responses in humans receiving a single intranasal administration of BPZE1. METHODS
Autor:
Emilie Wahren, Borgström, Gabrielle, Fröberg, Margarida, Correia-Neves, Fredrik Bosdotter, Atterfelt, Jan, Bellbrant, Robert, Szulkin, Erja, Chryssanthou, Kristian, Ängeby, Teghesti, Tecleab, Morten, Ruhwald, Peter, Andersen, Gunilla, Källenius, Judith, Bruchfeld
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 123
Interferon-γ release assays cannot differentiate latent from active tuberculosis (TB), nor identify the recently infected with increased risk of active disease. The objective of this study was to identify biomarkers of recent infection following exp
Autor:
Inger Julander, Gunilla Källenius, Lena Andersson, Maria Norrby, Peter Andersen, Emilie Wahren Borgström, Hans Gaines, Judith Bruchfeld, Ida Rosenkrands, Markus Maeurer, Teghesti Tecleab
Publikováno v:
Journal of Immunological Methods. 370:55-64
There is a large and growing worldwide need for reliable tests to diagnose active and latent tuberculosis (TB). Improved methodology for identifying individuals with true latent TB (LTBI), particularly those with a recent infection, would pave the wa
Autor:
G. Biberfeld, Patricia L. Earl, Gabriella Scarlatti, Bo Hejdeman, Eric Sandström, Merlin L. Robb, Karina Godoy-Ramirez, Robin J. Shattock, Richard Stout, Teghesti Tecleab, Britta Wahren, Andreas Bråve, Charlotta Nilsson
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131748 (2015)
PLoS ONE
PLoS ONE
Background We compared safety and immunogenicity of intradermal (ID) vaccination with and without electroporation (EP) in a phase I randomized placebo-controlled trial of an HIV-DNA prime HIV-MVA boost vaccine in healthy Swedish volunteers. Methods H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::286c99380007e0f3afefbe811f9180d2
http://hdl.handle.net/10044/1/26317
http://hdl.handle.net/10044/1/26317